The better goal is to lose fat while protecting muscle, strength, energy, and long-term metabolic health
If we are truly seeing a structural lifestyle change in consumers due to GLP-1s, then it requires rethinking how QSRs market themselves and the way they operate their locations
Tirzepatide demonstrates weight loss effects with noticeable changes during sustained treatment, especially over several weeks. Tirzepatide will be prescribed as a weekly injection
In 2024 semaglutide (Wegovy) became the first weight loss drug to also be approved for the reduction of risk of serious cardiovascular events in patients with cardiovascular (CV) disease and obesity and overweight
External resources For researchers serious about optimizing their GLP-1 protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, dosing tools, and a community of thousands who have navigated these exact dosing frequency questions
[DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted] 47.Wei X., Jia R., Wang G., Hong S., Song L., Sun B., Chen K., Wang N., Wang Q., Luo X., et al